132 related articles for article (PubMed ID: 12678804)
21. Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action.
Rodríguez-González A; Ramirez de Molina A; Fernández F; Lacal JC
Oncogene; 2004 Oct; 23(50):8247-59. PubMed ID: 15378008
[TBL] [Abstract][Full Text] [Related]
22. Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.
Arlauckas SP; Popov AV; Delikatny EJ
Mol Cancer Ther; 2014 Sep; 13(9):2149-58. PubMed ID: 25028471
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1).
Schiaffino-Ortega S; Baglioni E; Mariotto E; Bortolozzi R; Serrán-Aguilera L; Ríos-Marco P; Carrasco-Jimenez MP; Gallo MA; Hurtado-Guerrero R; Marco C; Basso G; Viola G; Entrena A; López-Cara LC
Sci Rep; 2016 Mar; 6():23793. PubMed ID: 27029499
[TBL] [Abstract][Full Text] [Related]
24. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression.
Ramírez de Molina A; Báñez-Coronel M; Gutiérrez R; Rodríguez-González A; Olmeda D; Megías D; Lacal JC
Cancer Res; 2004 Sep; 64(18):6732-9. PubMed ID: 15374991
[TBL] [Abstract][Full Text] [Related]
25. Anticancer bisquaternary heterocyclic compounds: a ras-ional design.
Campos J; Núñez C; Díaz JJ; Sánchez RM; Gallo MA; Espinosa A
Farmaco; 2003 Mar; 58(3):221-9. PubMed ID: 12620418
[TBL] [Abstract][Full Text] [Related]
26. New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1.
Castro-Navas FF; Schiaffino-Ortega S; Carrasco-Jimenez MP; Ríos-Marco P; Marco C; Espinosa A; Gallo MA; Mariotto E; Basso G; Viola G; Entrena-Guadix A; López-Cara LC
Future Med Chem; 2015; 7(4):417-36. PubMed ID: 25875870
[TBL] [Abstract][Full Text] [Related]
27. The choline kinase inhibitor hemicholinium-3 can inhibit mitogen-induced DNA synthesis independent of its effect on phosphocholine formation.
Crilly KS; Tomono M; Kiss Z
Arch Biochem Biophys; 1998 Apr; 352(1):137-43. PubMed ID: 9521826
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism.
Rodríguez-González A; Ramírez de Molina A; Bañez-Coronel M; Megias D; Lacal JC
Int J Oncol; 2005 Apr; 26(4):999-1008. PubMed ID: 15753995
[TBL] [Abstract][Full Text] [Related]
29. A novel 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazol with antitumoral activity via cell cycle arrest and induction of apoptosis.
Báñez-Coronel M; Rodríguez-González A; Martín-Cantalejo Y; Sáez B; Soto J; Villa MJ; Braña MF; Lacal JC
Int J Oncol; 2004 Oct; 25(4):1097-103. PubMed ID: 15375561
[TBL] [Abstract][Full Text] [Related]
30. Choline kinase active site provides features for designing versatile inhibitors.
Serran-Aguilera L; Nuti R; López-Cara LC; Ríos-Marco P; Carrasco MP; Marco C; Entrena A; Macchiarulo A; Hurtado-Guerrero R
Curr Top Med Chem; 2014; 14(23):2684-93. PubMed ID: 25515750
[TBL] [Abstract][Full Text] [Related]
31. ChoK-ing the Pathogenic Bacteria: Potential of Human Choline Kinase Inhibitors as Antimicrobial Agents.
Khalifa M; Few LL; See Too WC
Biomed Res Int; 2020; 2020():1823485. PubMed ID: 32695809
[TBL] [Abstract][Full Text] [Related]
32. QSAR of 1,1'-(1,2-ethylenebisbenzyl)bis(4-substitutedpyridinium) dibromides as choline kinase inhibitors: a different approach for antiproliferative drug design.
Campos J; Núñez MC; Rodríguez V; Gallo MA; Espinosa A
Bioorg Med Chem Lett; 2000 Apr; 10(8):767-70. PubMed ID: 10782682
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism.
Serrán-Aguilera L; Mariotto E; Rubbini G; Castro Navas FF; Marco C; Carrasco-Jiménez MP; Ballarotto M; Macchiarulo A; Hurtado-Guerrero R; Viola G; Lopez-Cara LC
Eur J Med Chem; 2020 Dec; 207():112797. PubMed ID: 32977218
[TBL] [Abstract][Full Text] [Related]
34. Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.
Rubbini G; Buades-Martín AB; Kimatrai-Salvador M; Entrena A; Gallo-Mezo MÁ; Ríos-Marco P; Marco C; Mattiuzzo E; Bortolozzi R; Mariotto E; Greco FA; Macchiarulo A; Carrasco-Jiménez MP; Viola G; López-Cara LC
Future Med Chem; 2018 Aug; 10(15):1769-1786. PubMed ID: 30043647
[TBL] [Abstract][Full Text] [Related]
35. Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.
Zech SG; Kohlmann A; Zhou T; Li F; Squillace RM; Parillon LE; Greenfield MT; Miller DP; Qi J; Thomas RM; Wang Y; Xu Y; Miret JJ; Shakespeare WC; Zhu X; Dalgarno DC
J Med Chem; 2016 Jan; 59(2):671-86. PubMed ID: 26700752
[TBL] [Abstract][Full Text] [Related]
36. Choline kinase alpha depletion selectively kills tumoral cells.
Bañez-Coronel M; Ramírez de Molina A; Rodríguez-González A; Sarmentero J; Ramos MA; García-Cabezas MA; García-Oroz L; Lacal JC
Curr Cancer Drug Targets; 2008 Dec; 8(8):709-19. PubMed ID: 19075594
[TBL] [Abstract][Full Text] [Related]
37. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.
Ramírez de Molina A; Gutiérrez R; Ramos MA; Silva JM; Silva J; Bonilla F; Sánchez JJ; Lacal JC
Oncogene; 2002 Jun; 21(27):4317-22. PubMed ID: 12082619
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiproliferative activity of amino-substituted benzimidazo[1,2-α]quinolines as mesylate salts designed by 3D-QSAR analysis.
Vušak D; Perin N; Martin-Kleiner I; Kralj M; Karminski-Zamola G; Hranjec M; Bertoša B
Mol Divers; 2017 Aug; 21(3):621-636. PubMed ID: 28667495
[TBL] [Abstract][Full Text] [Related]
39. From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design.
Ramírez de Molina A; Rodríguez-González A; Lacal JC
Cancer Lett; 2004 Apr; 206(2):137-48. PubMed ID: 15013519
[TBL] [Abstract][Full Text] [Related]
40. Pharmacophore-Based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1.
Serrán-Aguilera L; Nuti R; López-Cara LC; Mezo MÁ; Macchiarulo A; Entrena A; Hurtado-Guerrero R
Mol Inform; 2015 Jun; 34(6-7):458-66. PubMed ID: 27490389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
